Form 4 for CCCC C4 Therapeutics, Inc.
Accepted 2021-12-10 00:00:00 ET · period of report 2021-12-08 · accession 0001209191-21-069036 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-12-10 | 2021-12-08 | CCCC | Fisher Stewart | CSO | M - OptEx | $3.55 | +20.6K | 25.1K | +451% | +$73.0K |
| DM | 2021-12-10 | 2021-12-08 | CCCC | Fisher Stewart | CSO | M - OptEx | $0.00 | -20.6K | 37.7K | -35% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-08 | M | A | 403 | $4.98 | 43,306 | D | — | — | |
| 2 | Common | Common Stock | 2021-12-08 | M | A | 17,786 | $3.71 | 42,903 | D | — | — | |
| 3 | Common | Common Stock | 2021-12-08 | M | A | 2,373 | $2.11 | 25,117 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2021-12-08 | M | D | 403 | $0.00 | 203,994 | D | $4.98 · — to 2030-07-02 | 403 Common Stock | (F3) This option shall vest and become exercisable in 20 equal quarterly installments, with the first installment vesting on September 5, 2020. |
| 5 | Derivative | Stock Option (Right to Buy) | 2021-12-08 | M | D | 2,373 | $0.00 | 0 | D | $2.11 · — to 2026-07-12 | 2,373 Common Stock | (F1) This option is fully vested and exercisable as of the date hereof. |
| 6 | Derivative | Stock Option (Right to Buy) | 2021-12-08 | M | D | 17,786 | $0.00 | 37,728 | D | $3.71 · — to 2028-04-23 | 17,786 Common Stock | (F2) 20% of this option vested and became exercisable on May 1, 2019, with the remainder vesting in 16 equal quarterly installments thereafter. |